Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,205 public trials 1,002 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

NCT06996782

Conditions
Advanced or Metastatic Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Baltimore, Maryland, United States
View all 103 locations
View Trial Details
Recruiting

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

NCT05098132

Conditions
1st Line NSCLC, Advanced Solid Tumor, Bronchial Neoplasms, +11 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 47 locations
View Trial Details
Recruiting

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

NCT06899126

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • Orange Coast Memorial Medical Center Fountain Valley Fountain Valley, California, United States
  • California Research Institute Los Angeles, California, United States
  • Los Angeles Cancer Network (LACN) Los Angeles, California, United States
View all 237 locations
View Trial Details
Recruiting

A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer

NCT07253142

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Fujian Cancer Hospital Fu'zhou, Fujian, China
  • Cancer Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • The People's Hospital of Guangxi Zhuangzu Autonomous Region Nanning, Guangxi, China
View Trial Details
Recruiting

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

NCT07459634

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Valkyrie Clinical Trials, Inc. Los Angeles, California, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Carolina Blood and Cancer Care Rock Hill, South Carolina, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

NCT06476808

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • Local Institution - 0045 Columbus, Ohio, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

NCT06646276

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer, +8 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Local Institution - 0283 Hot Springs, Arkansas, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Mid Florida Hematology and Oncology Center Orange City, Florida, United States
View all 183 locations
View Trial Details
Recruiting

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

NCT07361497

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center Pc Daphne, Alabama, United States
  • Local Institution - 0780 Chandler, Arizona, United States
  • Intermountain Health Cancer Center Lutheran Hospital Golden, Colorado, United States
  • Medical Oncology Hematology Consultants, PA Newark, Delaware, United States
View all 256 locations
View Trial Details

Related conditions